Business
ACT Drugs: WHO Advises Super Branding To Reduce Confusion
Artemisinine Combination Therapy (ACT), which is the only recommended therapy for the treatment of uncomplicated malaria, should be branded in order to reduce confusion, WHO said.
The National Professional Officer, (Malaria) for WHO Nigeria, Dr Tolu Arowolo, made the statement in an interview with newsmen in Lagos, saying branding would help patients to use the appropriate medicines.“The only recommended drug for the treatment of uncomplicated malaria in Nigeria is what we call Artemisinine Combination Therapy, meaning a combination of anti-malaria that has artemisinine derivative in it.
“I am aware from my little research that people are using oral mono therapies, like artesunate for the treatment of malaria; it is very wrong,’’ she said.
Arowolo said that in spite of all the publicity given to ACT during the World Malaria Day, many people could still not identify it.
She explained that in Nigeria there were two types of anti-malaria combination drugs that met the ACT requirements for the treatment of malaria.
She said that the ACT drugs, artemether-lumefantrine and artemisinin-amodiaquine, were not easy for many Nigerians to pronounce and so many people got confused about them.
The officer said when the people, who bought anti-malaria drugs often accepted single dosage drugs, such as artesunate, which were easily available but not effective.
“The single dose drugs do not completely cure malaria and as a result they allow more anti-malaria resilient strains to develop.” Arowolo said.
She explained that super branding would involve creating an easy to recognise symbol for an ACT and putting that symbol on the packet so that people could identify it.
Arowlo said that until the government agreed to ban single therapy malaria drugs, the confusion about ACT drugs would continue, adding that super branding would make it easier for people to find the right medicine.
”Because of the names, which are not very easy for people to pronounce,
ccommunity health physicians, public health practitioners and drug manufacturers have advised to do super branding.
“They can write on the labelling of the drug or the package of the drug that this is an ACT.
“An example is the one that is coming under the Affordable Medicine Facility for Malaria, called AMFM. It has a logo of a green leaf coming from the government.
”If it is going to be at the shops, the manufacturer can also super brand it with ACT so that people can know that this is a drug that should be used for malaria.’’
Arowolo urged Nigerians to remain vigilant in the fight against malaria, which had remained endemic in the country.
She said people should do this by starting treatment with ACT within 24 hours of the onset of malaria.
She further urged Nigerians to endeavour to complete the three-day treatment because uncompleted treatment was another factor that led to drug resistant malaria.
Business
NCDMB, Dangote Refinery Unveil JTC On Deepening Local Content

Business
Industry Leaders Defend Local Content, … Rally Behind NCDMB

Business
Replace Nipa Palms With Mangroove In Ogoni, Group Urges FG, HYPREP

-
Business2 days ago
2027: Group Vows To Prevail On Diri To Dump PDP For APC
-
News2 days ago
FG Renames University of Maiduguri After Buhari …As Tinubu Pours Encomiums On Late President
-
News2 days ago
NUP Denies Planned Protest Over N32,000 Pension Increment
-
News2 days ago
Rivers PDP Debunks Sale Of LGA Election Forms
-
Niger Delta2 days ago
Bishop Mocks Fake Prophecy Seekers … As Priests Relive Challenges At Ordination Ceremony
-
Opinion2 days ago
Welcome! Worthy Future For R/S
-
Rivers2 days ago
Motor Spare Parts, Industrial Generators Dealers’ Union Swears Gets New Chairman in Port Harcourt
-
News2 days ago
South-South Contributes N34trn To Nigeria’s Economy In 2024 – Institute